Abiopharma

🔍 Smith Timothy Conrad (Executive)

Company: Lineage, Inc. (LINE)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 20,745 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 23,234.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Represents the grant of time-based restricted stock units ("RSUs"), which are contingent rights to receive shares of common stock ("Shares") on a one-for-one basis and which vest in equal annual installments as to 1/3 of the RSUs on each of April 1, 2027, 2028, 2029, subject to continued service with the Issuer through such dates.